Ethylphosphate



Compound IDCDAMM00568
Common nameEthylphosphate
IUPAC nameethyl dihydrogen phosphate
Molecular formulaC2H7O4P

Experimental data

Retention time8.51
Adduct[M+H]+
Actual mz127.014
Theoretical mz127.015
Error7.68
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3319

Identifiers and class information

Inchi keyZJXZSIYSNXKHEA-UHFFFAOYSA-N
SmilesO=P(O)(O)OCC
SuperclassOrganic acids and derivatives
ClassOrganic phosphoric acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)126.049
Computed dipole moment(dipole)7.438
Total solvent accessible surface area (SASA)318.864
Hydrophobic component of SASA (FOSA)137.596
Hydrophilic component of SASA (FISA)176.333
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)4.935
Total solvent accesible volume (volume)451.933
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)5
Free energy of solvation of dipole (dip^2/V)0.12242
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0221758
Globularity descriptor (glob)0.893185
Predicted polarizability in cubic angstroms (QPpolrz)9.364
Predicted hexadecane/gas partition coefficient (QPlogPC16)3.75
Predicted octanol/gas partition coefficient (QPlogPoct)9.71
Predicted water/gas partition coefficient (QPlogPw)8.659
Predicted octanol/water partition coefficient (QPlogPo/w)0.022
Predicted aqueous solubility (QPlogS)-0.425
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.395
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.355
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)13.519
Predicted brain/blood partition coefficient (QPlogBB)-1.139
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)8.129
Predicted skin permeability, log Kp (QPlogKp)-4.385
PM3 calculated ionization potential (IP(ev))10.317
PM3 calculated electron affinity (EA(eV))-0.27
Number of likely metabolic reactions (#metab)0
Prediction of binding to human serum albumin (QPlogKhsa)-1.307
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)47.317
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)72.979
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q9HBW0LPAR2Lysophosphatidic acid receptor Edg-4T39380SEA
Q99500S1PR3Sphingosine 1-phosphate receptor Edg-3T11241SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9H1C0LPAR5Lysophosphatidic acid receptor 5T18616SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA
P51575P2RX1P2X purinoceptor 1T69091SEA
O95749GGPS1GeranyltranstransferaseT86528SEA
O95749GGPS1GeranyltranstransferaseT86528SEA
P53602MVDDiphosphomevalonate decarboxylaseT96862SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T11241DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q99500S1PR3
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1

Copyright © 2025